Quotes Decoy Therapeutics Inc. London S.E.

Stocks

End-of-day quote London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Stock exchange

London S.E.- p -.--% 0 p

Markets		Price	Change	Volumes
Nasdaq	DCOY	2.880USD	-3.36%	31.75K $
CBOE	DCOY	3.010USD	-4.14%	1.51K $

markets

Capital turnover ratio

Float rotation

Market Cap (GBX)

1,886,932

Market Cap (USD)

1,886,932

Net sales (USD)

Number of employees

Sales / Employee (USD)

Free-Float

99.52 %

Free-Float capitalization (GBX)

1,877,967

Free-Float capitalization (USD)

1,877,967

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DECOY THERAPEUTICS INC.	-.--%	-.--%	-	-	1.89M
WUXI APPTEC CO., LTD.	+0.41%	-2.07%	+41.26%	+95.40%	69.02B
ARGENX SE	-1.21%	+0.67%	+42.73%	+89.77%	66.32B
INSMED INCORPORATED	+0.04%	+4.36%	-11.72%	+459.54%	27.66B
BIONTECH SE	-0.90%	-7.65%	+2.45%	-15.50%	25.84B
WUXI BIOLOGICS (CAYMAN) INC.	-3.00%	-2.90%	+39.40%	+9.41%	26.54B
GENMAB A/S	-0.16%	+1.25%	+25.10%	-18.02%	20.4B
PHARMAESSENTIA CORPORATION	+3.45%	-13.46%	+222.69%	+389.50%	17.63B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.49%	-4.88%	-0.41%	+530.26%	15.15B
EXELIXIS, INC.	+1.03%	+7.00%	+59.98%	+160.03%	14.65B
Average	-0.18%	-1.37%	+46.83%	+188.93%	28.32B
Weighted average by Cap.	-0.37%	-0.83%	+41.59%	+148.21%